Formoterol Fumarate; Mometasone Furoate Patent Expiration
Formoterol Fumarate; Mometasone Furoate is Used for managing and controlling symptoms of asthma. It was first introduced by Organon Llc
Formoterol Fumarate; Mometasone Furoate Patents
Given below is the list of patents protecting Formoterol Fumarate; Mometasone Furoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Dulera |
US7067502 (Pediatric) | Combinations of formoterol and mometasone furoate for asthma |
Nov 21, 2020
(Expired) | Organon Llc |
| Dulera |
US7566705 (Pediatric) | Combination of formoterol and mometasone furoate for asthma |
Nov 21, 2020
(Expired) | Organon Llc |
| Dulera | US7067502 | Combinations of formoterol and mometasone furoate for asthma |
May 21, 2020
(Expired) | Organon Llc |
| Dulera | US7566705 | Combination of formoterol and mometasone furoate for asthma |
May 08, 2020
(Expired) | Organon Llc |
| Dulera | US6068832 | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
Aug 27, 2017
(Expired) | Organon Llc |
| Dulera |
US5889015 (Pediatric) | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Dulera |
US6057307 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Dulera | US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Dulera | US6057307 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Dulera | US6677323 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
Formoterol Fumarate; Mometasone Furoate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List